Unknown

Dataset Information

0

IL-2R? abundance differentially tunes IL-2 signaling dynamics in CD4+ and CD8+ T cells.


ABSTRACT: Interleukin-2 (IL-2) stimulates both activated CD4+ and CD8+ T cells to proliferate. IL-2 signals through an identical receptor complex and promotes the same dose-dependent phosphorylation of the canonical transcription factor STAT5 in both cell types. Despite this, CD8+ T cells enter the S phase earlier and proliferate to a greater extent than do CD4+ T cells in response to IL-2. We identified distinct IL-2 signaling dynamics in CD4+ and CD8+ T cells. In IL-2-stimulated CD8+ T cells, STAT5 phosphorylation increased rapidly and was sustained for 6 hours. In contrast, CD4+ T cells had a biphasic response, with maxima at 15 min and 2 to 4 hours after stimulation. Both cell types required vesicular trafficking, but only CD4+ T cells required new protein synthesis to maintain high phosphorylation of STAT5. Two subunits of the IL-2 receptor, IL-2R? and IL-2R?, were twice as abundant in CD8+ T cells than in CD4+ T cells. Reduction of IL-2R? abundance by 50% was sufficient to convert CD8+ T cells to a CD4+ T cell-like signaling pattern and delay S phase entry. These results suggest that the larger pool of IL-2R? chains in CD8+ T cells is required to sustain IL-2 signaling and contributes to the quantitatively greater proliferative response to IL-2 relative to that of CD4+ T cells. This cell type-specific difference in IL-2R? abundance appears to tune responses, potentially preventing extensive, autoimmune proliferation of CD4+ T cells, while still enabling sufficient proliferation of CD8+ T cells to control viral infections.

SUBMITTER: Smith GA 

PROVIDER: S-EPMC5741096 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

IL-2Rβ abundance differentially tunes IL-2 signaling dynamics in CD4<sup>+</sup> and CD8<sup>+</sup> T cells.

Smith Geoffrey A GA   Taunton Jack J   Weiss Arthur A  

Science signaling 20171219 510


Interleukin-2 (IL-2) stimulates both activated CD4<sup>+</sup> and CD8<sup>+</sup> T cells to proliferate. IL-2 signals through an identical receptor complex and promotes the same dose-dependent phosphorylation of the canonical transcription factor STAT5 in both cell types. Despite this, CD8<sup>+</sup> T cells enter the S phase earlier and proliferate to a greater extent than do CD4<sup>+</sup> T cells in response to IL-2. We identified distinct IL-2 signaling dynamics in CD4<sup>+</sup> and CD  ...[more]

Similar Datasets

| S-EPMC3058680 | biostudies-literature
| S-EPMC3478487 | biostudies-literature
| S-EPMC5564451 | biostudies-literature
| S-EPMC8027001 | biostudies-literature
| S-EPMC9622814 | biostudies-literature
| S-EPMC2809970 | biostudies-literature
| S-EPMC3871703 | biostudies-literature
| S-EPMC4805116 | biostudies-literature
| S-EPMC4546887 | biostudies-literature
| S-EPMC10152038 | biostudies-literature